retatrutide a1c More data on dropped today at the ADA conference!! Reta is an investigational -not FDA approved yet- once-weekly medication that simultaneously activates the GIP, GLP-1, and glucagon receptors In the Phase Retatrutide Mechanism, Clinical Results and
Description
However, it is crucial to understand that microdosing GLP-1 is not an evidence-based practice and lacks formal clinical trial data supporting its efficacy or safety

BMJ (2012) 344:d7771.10.1136/bmj.d7771 66 SkibickaKP

It can also lead to a decrease in basal metabolic rate, making it harder to maintain weight loss over time

In approved incretin therapy, glucagon is suppressed

GLP-1s work by delaying gastric emptying.) Ginger supplements or ginger tea can sometimes alleviate nausea
